Member Info for The.Italian

glad it's out.only had time for a quick glance but will have proper look later.

he is the sole director and shareholder in cbderma.however he is also one of two partners in beagle partners llp.see my 15.09 post yesterday with link.i have tried posting a link yesterday to the linkedin page of the other partner ,david manuel,but it does not seem to work.if you can access it it's worth a read,wearing the appropriately coloured spectacles of course(not rose tinted).strangely i can no longer access it on my computer but i think that is a problem at my end.

ok fair enough BE.i did wonder but obviously took it the wrong way.good job I'm not really italian though (cosa nostra and all that).i don't imagine they are planning to start selling face cream etc.but if they do end up producing a more effective delivery system for manufacturers who wish to use it then i imagine it could be extremely lucrative.anyway we re a long way off that atm.other fish to fry first i hope.

bag of chips i agree with your cautious approach to this (its just a possible incidental to the main ED focus) but you might find the linkedin profile of david manuel, parkers partner in beagle partners llp, of some interest. needs to be read with circumspection ,of course,but perhaps there is more substance to the situation than first appears. looks like cbderm was was formed specifically with this mind.,or at least thats my takehttps://uk.linkedin.com/in/dr-david-manuel

hardly a balanced or fair assessment of the situation or my comments on it.to be honest your post is,imo,nonsense.if they had announced they were abandoning all other activities it might have some relevance,but as they have not, it does not. just another possible line of exploration.previous respect all gone now I'm afraid. far too much bile and bias for my taste

i would suggest that anyone who has not yet done so should listen to barders video today on the cbd update.as always with these, watch them with a very liberal does of scepticism, as they are entirely self promotional, what is interesting about this one is that it gives an insight into the focus re CCBD, which is not made explicit in the RNS. it seems the initial focus is on the cosmeceutical market, under which products may not make medical claims, but equally do not have to undergo pharma trials to prove claims. think along the lines of a superior (or at least perceived by the consumer as such) skin cream, that sort of thing. certainly not wishing to overstate anything here and it may all come to nothing, but if successful, has the potential to be marketed much sooner than something which requires trials. still very very early days, but important i think that investors at least understand the targeted market etc.

odysseus I'm talking solely about the cbd potential.pretty sure that wasn't around in 2002.

thank you jonah.nice to hear from a genuine italian (as you know I'm a phoney).i agree the motto is stick with it.i did have some interest in the CBD field a while ago.but currently none of my investment are involved in any way with that,apart from FUM, but its interesting to see something like this at a very early stage. very very early days but enormous potential imo

https://beaglepartners.com/# i think this may have something to do with it.research parker and his bristol address.

fair enough BE.i have never personally e mailed FUM for any of its officers.i have found that you can sometimes build up a quasi relationship with an individual, but of course that can always change.

agreed L/F.

no BE, just email one of them. i usually find if i email a named individual it does not get dealt with by the pr company.no guarantee of course but thats what i suggest.if it was me would email barder.he is the ceo after all

good god!the s/p has actually moved.

very interesting article indeed Petebo.i was particularly interested to see the figure for the dropkick murphy and springsteen concert. over 5.9m .when you look on youtube it has something over 216,000,which was the figure i was going on when i expressed surprise how low it was.makes one realise how difficult it is to judge the actual impact/viewing figures of performances without access to all the data, which is very difficult to compile.i hope this is a small indication that melody's reach is already greater than some of the figures we have seen, suggest.

sorry BE i don't think it is rambling at all.he is just outlining the range of areas of potential/possible application.seems perfectly clear to me.agree with the stability point though.

morning be..glad you liked the suggestion .i hope to hear further. glad also to see today's RNS, simply from the point of view that it fulfils (albeit a few days late) the indication in the interview that we would be updated on this in july. not going to comment on the substance as its very early days to attach any to it , but pleased that information time lines have been adhered to.

be you are very worked up about this aren't you. perhaps i can politely suggest that you email barder or james apprising then of your very strong opinion that their chosen form of wording is laying them open to law suits by disappointed investors and to serious repetitional damage in the eyes of the pharma industry as producers of duplicitous and misleading information.if you do I'm sure we will all be very interested to see their response. i fear this is the only way you will be able to resolve this issue to your satisfaction.of course you may not get a reply but no harm in trying if you feel so strongly about it.

i meant to add obvious strong us emphasis as well.

yes this one looks as though it could be quite interesting.not clear what melody's involvement will be, but the write up for Scary (excuse the familiarity as I've never heard of him before but its quite difficult to do his name in full) is pretty impressive even allowing for the usual hyperbole. interesting that its live nation based as well.

damn you've beaten me to it.any idea what it is ?.i saw it curtesy of mushroom man on twitter.